Farmacosmo Statistics

Total Valuation

Farmacosmo has a market cap or net worth of EUR 16.11 million. The enterprise value is 22.36 million.

Market Cap	16.11M
Enterprise Value	22.36M

Important Dates

The last earnings date was Monday, September 29, 2025.

Earnings Date	Sep 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Farmacosmo has 38.81 million shares outstanding.

Current Share Class	34.72M
Shares Outstanding	38.81M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.20%
Owned by Institutions (%)	3.48%
Float	31.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.27
PB Ratio	2.08
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.63
EV / Sales	0.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.79

Financial Position

The company has a current ratio of 0.92, with a Debt / Equity ratio of 1.02.

Current Ratio	0.92
Quick Ratio	0.32
Debt / Equity	1.02
Debt / EBITDA	n/a
Debt / FCF	-3.80
Interest Coverage	-2.70

Financial Efficiency

Return on equity (ROE) is -46.84% and return on invested capital (ROIC) is -12.28%.

Return on Equity (ROE)	-46.84%
Return on Assets (ROA)	-6.87%
Return on Invested Capital (ROIC)	-12.28%
Return on Capital Employed (ROCE)	-32.39%
Revenue Per Employee	617,023
Profits Per Employee	-50,353
Employee Count	95
Asset Turnover	1.90
Inventory Turnover	6.48

Taxes

In the past 12 months, Farmacosmo has paid 113,700 in taxes.

Income Tax	113,700
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.41% in the last 52 weeks. The beta is 0.28, so Farmacosmo's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	-18.41%
50-Day Moving Average	0.45
200-Day Moving Average	0.55
Relative Strength Index (RSI)	45.33
Average Volume (20 Days)	16,095

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Farmacosmo had revenue of EUR 59.23 million and -4.83 million in losses. Loss per share was -0.12.

Revenue	59.23M
Gross Profit	-79,591
Operating Income	-3.42M
Pretax Income	-4.65M
Net Income	-4.83M
EBITDA	-1.72M
EBIT	-3.42M
Loss Per Share	-0.12

Full Income Statement

Balance Sheet

The company has 2.01 million in cash and 7.87 million in debt, giving a net cash position of -5.86 million or -0.15 per share.

Cash & Cash Equivalents	2.01M
Total Debt	7.87M
Net Cash	-5.86M
Net Cash Per Share	-0.15
Equity (Book Value)	7.73M
Book Value Per Share	0.19
Working Capital	-1.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.04 million and capital expenditures -35,366, giving a free cash flow of -2.07 million.

Operating Cash Flow	-2.04M
Capital Expenditures	-35,366
Free Cash Flow	-2.07M
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross margin is -0.13%, with operating and profit margins of -5.77% and -8.16%.

Gross Margin	-0.13%
Operating Margin	-5.77%
Pretax Margin	-7.86%
Profit Margin	-8.16%
EBITDA Margin	-2.90%
EBIT Margin	-5.77%
FCF Margin	n/a

Dividends & Yields

Farmacosmo does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-30.01%
FCF Yield	-12.86%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Farmacosmo has an Altman Z-Score of 1.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.89
Piotroski F-Score	1